China SXT Pharmaceuticals, Inc. (SXTC) — Institutional Holders, Q3 2024
3 institutional investment managers reported a SXTC position on SEC Form 13F-HR for the quarter ended September 30, 2024, with a combined reported value of $6.4K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
SXTC 13F holders ranked 1–3 of 3
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q2 2024 |
|---|---|---|---|---|---|
| 1 | BANK OF MONTREAL#1 · 10,000 sh | 10,000 | $6.4K | — | 0.0% |
| 2 | PROEQUITIES#2 · 0 sh | 0 | $0.00 | — | New |
| 3 | ACADIAN ASSET MANAGEMENT#3 · 379 sh | 379 | $0.00 | — | -86.3% |
Source: Form 13F-HR filings on SEC EDGAR, Q3 2024. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q2 2024 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.